
|Videos|January 26, 2021
Fumarates for Treatment of RMS
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Orexin Agonist Oveporexton for Narcolepsy Type 1
2
FDA Grants RMAT Designation to Sasineprocel for Parkinson Disease
3
High-Dose N-Acetyl Cysteine Associated With Reduced GFAP Levels in Phase 2 Progressive MS Study
4
FDA Accepts SL1009 Resubmission for PDCD, Sets December PDUFA Date
5































